Schedule 13G ownership disclosure
Arcutis Biotherapeutics Inc
Security class unavailable · CUSIP: 03969K108
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 1.6200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-24-000094
- Form type
- SC 13G
- Filer
- Arcutis Biotherapeutics, Inc.
- CIK
- CIK 1787306
- Filed
- Jan 23, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership